Clinical Trial

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Name: Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC — clinical trial record (NCT04340258)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

To Study Perioperative PD-1 Inhibitor and Cesium-131 Interstitial Brachytherapy in patients with locally recurrent HNSCC eligible for salvage surgery.

Trial Details

NCT Number	NCT04340258
Lead Sponsor	University of Cincinnati Collaborators: IsoRay Medical, Inc.
Conditions	HNSCC
Enrollment	50 participants
Start Date	2021-02-04
Primary Completion	2025-06-03 (estimated)
Study Completion	2026-09-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-09